Cryptic genomic lesions in adverse-risk acute myeloid leukemia identified by integrated whole genome and transcriptome sequencing

Affiliations

• ¹ Department of Medical Biophysics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
• ² Genomics Technology Program, Ontario Institute for Cancer Research, Toronto, ON, Canada.
• ³ Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
• ⁴ PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, ON, Canada.
• ⁵ Department of Laboratory Medicine and Pathobiology, University of Toronto and the Laboratory Medicine Program, University Health Network, Toronto, ON, Canada.
• ⁶ Department of Medical Biophysics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada. mark.minden@uhn.ca.
• ⁷ Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. mark.minden@uhn.ca.
• ⁸ Department of Medical Biophysics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada. jdmcpherson@ucdavis.edu.
• ⁹ Genomics Technology Program, Ontario Institute for Cancer Research, Toronto, ON, Canada. jdmcpherson@ucdavis.edu.
• ¹⁰ Biochemistry and Molecular Medicine, University of California, Davis, Sacramento, CA, USA. jdmcpherson@ucdavis.edu.